Search

Issue
Title
Authors
An assessment of efficacy and safety of replacement therapy with subcutaneous immunoglobulin 16.5% administered by rapid push method in patients with inborn errors of immunity: the results of a prospective multicenter study
Avedova A.Y., Deripapa E.V., Rodina Y.A., Mukhina A.A., Latysheva E.A., Yukhacheva D.V., Burlakov V.I., Kan N.Y., Bogdanova D.V., Moiseeva A.A., Kuzmenko N.B., Nesterenko Z.A., Deordieva E.A., Ogneva A.L., Bludova V.O., Roppelt A.A., Fomina D.S., Zinovieva N.V., Sevostyanova Y.N., Kalmetyeva L.R., Prolygina D.D., Barycheva L.Y., Selezneva O.S., Shakhova N.V., Laba O.M., Vlasova E.V., Gorenkova A.V., Timofeeva E.V., Trusova O.V., Guseva M.N., Yudina N.B., Ibisheva A.K., Bambaeva Z.V., Mashkovskaya D.V., Isakova S.N., Shakirova A.R., Selina E.Y., Shilova T.V., Zubova E.S., Krasilova E.V., Khabaeva I.U., Kitova E.V., Mandzhieva A.G., Starikova S.Y., Pavlova T.B., Tyulyakova E.N., Levin P.A., Shcherbina A.Y.
Efficiency and safety of Innonafactor in prevention of bleeding episodes in patients with severe and moderate hemophilia B: Results of part 1 of phase II-III clinical trial
Andreeva T.A., Zorenko V.Y., Davydkin I.L., Konstantinova V.N., Zalepukhina O.E., Klimova N.I., Mishin G.V., Krechetova A.V., Kurtov I.V., Shamina M.S., Fatenkova E.S., Gusyakova O.A., Shuster A.M., Kudlai D.A., Lukyanov S.V., Borozinets A.Y.
Statistically significant improvement in hemophilia A control: a retrospective analysis of the effectiveness and safety of emicizumab in children with severe and inhibitor forms of hemophilia A
Petrov V.Y., Lavrentyeva I.N., Vdovin V.V., Svirin P.V.
Pharmacokinetic parameters of simoctocog alfa in children with hemophilia A without inhibitors in real clinical practice
Zharkov P.A., Florinskiy D.B., Shiller E.E.
The use of emicizumab in children with hemophilia A without inhibitors in the real-world clinical setting
Zharkov P.A., Voronin K.A., Florinskiy D.B., Andreeva T.A., Batdiyeva D.B., Goroshkova M.Y., Ignatyev S.V., Kreining V.V., Medova K.Y., Osmulskaya N.S., Petrov V.Y., Plaksina O.I., Shiller E.E., Elgakaeva K.M.
Experience with the use of Hizentra, an immunoglobulin preparation for subcutaneous administration, in patients with primary immunodeficiency diseases
Avedova A.Y., Rodina Y.А., Yukhacheva D.V., Burlakov V.I., Deripapa E.V., Shcherbina A.Y.
A comparative efficacy and safety of using ferrous and ferric iron preparations for management of iron-deficiency anaemia
Lebedev V.V., Demikhov V.G., Dmitriev A.V., Aiari M., Fomina M.A.
Intravenous 5% normal human immunoglobulin I.G. Vena in therapy of primary immunodeficiencies in children
Smirnova I.N., Rodina Y.A., Deripapa E.V., Dibirova S.A., Shcherbina A.Y.
Efficacy and safety of Innonafactor in on-demand treatment of patients with severe and moderate hemophilia B: Results of part 2 of phase II-III clinical trial
Davydkin L.I., Zorenko V.Y., Andreeva T.A., Konstantinova V.N., Zalepukhina O.E., Klimova N.I., Mishin G.V., Krechetova A.V., Kurtov I.V., Shamina M.S., Fatenkova E.S., Gusyakova O.A., Shuster A.M., Kudlai D.A., Lukyanov S.V., Borozinets A.Y.
1 - 9 of 9 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"